|
Dr. Quay has been employed by the Company since August 2000 as Chairman of the Board President and Chief Executive Officer. In 1999 Dr. Quay founded and was Chairman President and CEO of Atossa HealthCare Inc. which focused on the development of a proprietary platform of diagnostics and treatments related to breast cancer risk assessment and therapeutics and other women’s health care products. Atossa was acquired by the Company in August 2000. In 1991 Dr. Quay founded Sonus Pharmaceuticals Inc. a company engaged in the research and development of drug delivery systems and oxygen delivery products based on its emulsion and surfactant technology where he served as Chief Executive Officer President and a director until June 1999. In 1984 Dr. Quay founded Salutar Inc. to develop contrast agents for magnetic resonance imaging. Two pharmaceuticals OmniScan(R) and TeslaScan(R) were invented by Dr. Quay at Salutar and are now FDA-approved for sale in the United States and other countries. Dr. Quay has authored more than 100 papers in diagnostic imaging oncology and biochemistry and has received 48 U.S. patents. Dr. Quay graduated from the University of Michigan Medical School where he received an M.A. and Ph.D. in Biological Chemistry in 1974 and 1975 respectively and an M.D. in 1977. Dr. Quay did post-graduate work in the chemistry department at the Massachusetts Institute of Technology and received his residency training at the Massachusetts General Hospital Harvard Medical School. From 1980 to 1986 he was a faculty member at Stanford University School of Medicine. | 